Duruisseaux, M., Besse, B., Cadranel, J., Pérol, M., Mennecier, B., Bigay-Game, L., . . . Moro-Sibilot, D. (2017). Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): A French nationwide cohort retrospective study. Oncotarget.
Chicago Style aipamenaDuruisseaux, Michaël, et al. "Overall Survival With Crizotinib and Next-generation ALK Inhibitors in ALK-positive Non-small-cell Lung Cancer (IFCT-1302 CLINALK): A French Nationwide Cohort Retrospective Study." Oncotarget 2017.
MLA aipamenaDuruisseaux, Michaël, et al. "Overall Survival With Crizotinib and Next-generation ALK Inhibitors in ALK-positive Non-small-cell Lung Cancer (IFCT-1302 CLINALK): A French Nationwide Cohort Retrospective Study." Oncotarget 2017.